ANTAGONISM OF VOLTAGE-GATED CALCIUM CHANNELS IN SMALL CELL CARCINOMAS OF PATIENTS WITH AND WITHOUT LAMBERT-EATON MYASTHENIC SYNDROME BY AUTOANTIBODIES OMEGA-CONOTOXIN AND ADENOSINE

被引：0
|
作者：
DEAIZPURUA, HJ
LAMBERT, EH
GRIESMANN, GE
OLIVERA, BM
LENNON, VA
机构：
[1] MAYO CLIN & MAYO FDN,DEPT IMMUNOL,NEUROIMMUNOL LAB,ROOM 828,GUGGENHEIM BLDG,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT NEUROL,NEUROIMMUNOL LAB,ROCHESTER,MN 55905
[3] UNIV MINNESOTA,DEPT NEUROL,MINNEAPOLIS,MN 55455
[4] UNIV UTAH,DEPT BIOL,SALT LAKE CITY,UT 84112
来源：
CANCER RESEARCH | 1988年 / 48卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4719 / 4724
页数：6
相关论文
共 50 条
  • [41] P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer
    Wirtz, PW
    Lang, B
    Graus, F
    van den Maagdenberg, AMJM
    Saiz, A
    Gans, PAD
    Twijnstra, A
    Verschuuren, JJGM
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 164 (1-2) : 161 - 165
  • [42] Screening for small-cell lung cancer: A follow-up study of patients with Lambert-Eaton myasthenic syndrome
    Titulaer, Maarten J.
    Wirtz, Paul W.
    Willems, Luuk N. A.
    van Kralingen, Klaas W.
    Smitt, Peter A. E. Sillevis
    Verschuuren, Jan J. G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4276 - 4281
  • [43] HETEROGENEITY OF CALCIUM-CHANNEL AUTOANTIBODIES DETECTED USING A SMALL-CELL LUNG-CANCER LINE DERIVED FROM A LAMBERT-EATON MYASTHENIC SYNDROME PATIENT
    JOHNSTON, I
    LANG, B
    LEYS, K
    NEWSONDAVIS, J
    NEUROLOGY, 1994, 44 (02) : 334 - 338
  • [44] VOLTAGE-DEPENDENT CA-2+ INFLUX BY HUMAN SMALL-CELL CARCINOMAS (SCC) IS IMPAIRED BY IG FROM LAMBERT-EATON MYASTHENIC SYNDROME (LES)
    DEAIZPURUA, HJ
    GRIESMANN, GE
    LAMBERT, EH
    LENNON, VA
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 40 - 41
  • [45] LAMBERT-EATON MYASTHENIC SYNDROME WITH AUTONOMIC AND CEREBELLAR FEATURES ASSOCIATED WITH VOLTAGE GATED CALCIUM CHANNEL AND ANTI-CV2/CRMP5 ANTIBODIES
    Parkinson, M. H.
    Ellis, C. M.
    Delamont, R. S.
    Sargur, R.
    Egner, W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (01): : 114 - 114
  • [46] HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma
    Wirtz, PW
    Willcox, N
    Roep, BO
    Lang, B
    Wintzen, AR
    Newsom-Davis, J
    Verschuuren, JJ
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 200 - 201
  • [47] Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor
    Imai, Shungo
    Mitsuboshi, Satoru
    Hori, Satoko
    Suzuki, Shigeaki
    EUROPEAN JOURNAL OF CANCER, 2023, 180 : 1 - 3
  • [48] A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
    Bradbury, P
    Lang, B
    Vincent, A
    Han, C
    Talbot, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 669S - 669S
  • [49] Association of Lambert-Eaton myasthenic syndrome (LEMS) with paraneoplastic cerebellar degeneration (PCD) in patients with small-cell lung cancer (SCLC)
    Dalmau, JO
    Lang, B
    Graus, F
    Mason, WP
    Honnorat, J
    Delattre, JY
    Antoine, JC
    Rosenfeld, MR
    NewsomDavis, J
    Posner, JB
    NEUROLOGY, 1997, 48 (03) : 1020 - 1020
  • [50] A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
    Bradbury, P
    Lang, B
    Vincent, A
    Han, C
    Talbot, D
    BRITISH JOURNAL OF CANCER, 2004, 91 : S28 - S28
12345